RISK‐ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA‐EPOCH‐R. (June 2017) - Dunleavy, K.; Roschewski, M.; Abramson, J.S.; Link, B.; Parekh, S.; Jagadeesh, D.; Bierman, P.; Watson, P.R.; Peace, D.; Hanna, W.; Powell, B.; Melani, C.; et al.